Hemodiafiltration Versus Hemodialysis in Older People
Condition(s) studied
Investigational drug(s) / intervention(s)
High-flux hemodialysis: High-flux hemodialysis removes small and middle molecular solutes through the mechanism of diffusion.
Hemodiafiltration: Hemodiafiltration removes solutes using convection which allows for more epuration of middle molecular solutes.
Study summary
This study will compare the impact of two hemodialysis techniques on fatigue and post-dialysis recovery time in patients aged 85 years and older. These two techniques are high-flux hemodialysis (HD) and hemodiafiltration (HDF).
Patients will receive the treatment over two periods: if period 1 is HD then period 2 will be HDF. Every patient will be his/her own control, this is why it is called cross-over. Each period will last three months. Between the two periods, patients will receive a traditional low-flux hemodialysis.
These two techniques are widely used worldwide and their side-effects are well-known and do not put the patients at risk. HDF has been shown to improve survival in patients with a mean age of 58 years. But a previous study from the investigators' group showed that HDF causes a prolonged recovery time in older patients. This randomized trial aims to elucidate this question.
Eligibility
Primary outcome measure(s)
- Change in dialysis recovery time — Three months
Time in minutes that the patient needs after dialysis to recover energy
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| AUB Santé | Bretagne | France | Recruiting |
| AIDER | Grabels | France | Recruiting |
| ECHO | Le Mans | France | Recruiting |
| Aura Paris | Paris | France | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07278973 on ClinicalTrials.gov ↗ ← All trials in France